Editorial pubs.acs.org/chemneuro
ACS Editors’ Choice: Providing Recognition to Authors and Open Access to the Community he Editors of ACS Chemical Neuroscience have been actively discussing submissions and making the most of ACS Editors’ Choice. Articles selected as ACS Editors’ Choice are granted free public access by the ACS to highlight research of importance to the global scientific community, and are sometimes featured in C&E News as well, thus giving significant attention to the work. ACS Editors’ Choice articles exemplify the ACS’s commitment to improving people’s lives through the transforming power of chemistryeven in translational space, chemistry is at the heart of everythingit is the Central science. The ACS Editors’ Choice program launched in 2014, and the Editors of ACS Chemical Neuroscience made three selections in that inaugural year covering a diverse range of topics. Noting the impact of these now open access articles, and positive feedback from authors, we expanded our nominations in 2015, and nine Editors’ Choice papers from ACS Chemical Neuroscience were approved. As a result, these have become highly read and cited manuscripts, drawing attention to both the work and the Journal. The year 2016 is no exception, and the count continues to increase. We welcome your high quality and high impact manuscripts, and appreciate the trust you place in ACS Chemical Neuroscience to convey and disseminate your scienceACS Editors’ Choice is a new vehicle for us (Editors nominate and a panel of ACS Publications Managing Editors, who are each Ph.D.-level scientists and are conversant with the current scientific literature and research, will make the final selection of articles for inclusion in the program)1 to further help your work be disseminated to the broadest possible audience and to enhance exposure. Selective Enhancement of Dopamine Release in the Ventral Pallidum of Methamphetamine-Sensitized Mice Kristen A. Stout, Amy R. Dunn, Kelly M. Lohr, Shawn P. Alter, Rachel A. Cliburn, Thomas S. Guillot, and Gary W. Miller Publication Date (Web): August 8, 2016 ACS Editors’ Choice Date: August 18, 2016 Volume 7, Issue 10 DOI: 10.1021/acschemneuro.6b00131 Impaired Brain Dopamine and Serotonin Release and Uptake in Wistar Rats Following Treatment with Carboplatin Sam V. Kaplan, Ryan A. Limbocker, Rachel C. Gehringer, Jenny L. Divis, Gregory L. Osterhaus, Maxwell D. Newby, Michael J. Sofis, David P. Jarmolowicz, Brooke D. Newman, Tiffany A. Mathews, and Michael A. Johnson Publication Date (Web): May 4, 2016 ACS Editors’ Choice Date: May 22, 2016 Volume 7, Issue 6 DOI: 10.1021/acschemneuro.5b00029 Central Nervous System Multiparameter Optimization Desirability: Application in Drug Discovery
T
© 2016 American Chemical Society
Travis T. Wager, Xinjun Hou, Patrick R. Verhoest, and Anabella Villalobos Publication Date (Web): March 18, 2016 ACS Editors’ Choice Date: April 11, 2016 Volume 7, Issue 6 DOI: 10.1021/acschemneuro.6b00029 Serotonergic Modulation as Effective Treatment for Dravet Syndrome in a Zebrafish Mutant Model Jo Sourbron, Henning Schneider, Angéla Kecskés, Yusu Liu, Ellen M. Buening, Lieven Lagae, Ilse Smolders, and Peter de Witte Publication Date (Web): January 29, 2016 ACS Editors’ Choice Date: February 17, 2016 Volume 7, Issue 5 DOI: 10.1021/acschemneuro.5b00342 Maternal Pharmacokinetics and Fetal Disposition of (±)-Citalopram during Mouse Pregnancy Juan C. Velasquez, Nick Goeden, Skyla M. Herod, and Alexandre Bonnin Publication Date (Web): January 14, 2016 ACS Editors’ Choice Date: January 30, 2016 Volume 7, Issue 3 DOI: 10.1021/acschemneuro.5b00287 Direct High Affinity Interaction between Aβ42 and GSK3α Stimulates Hyperphosphorylation of Tau. A New Molecular Link in Alzheimer’s Disease? Christopher J. Dunning, Gavin McGauran, Katarina Willén, Gunnar K. Gouras, David J. O’Connell, and Sara Linse Publication Date (Web): November 30, 2015 ACS Editors’ Choice Date: December 15, 2015 Volume 7, Issue 2 DOI: 10.1021/acschemneuro.5b00262 Therapeutic Effect of a Synthetic RORα/γ Agonist in an Animal Model of Autism Yongjun Wang, Cyrielle Billon, John K. Walker, and Thomas P. Burris Publication Date (Web): December 1, 2015 ACS Editors’ Choice Date: December 12, 2015 Volume 7, Issue 2 DOI: 10.1021/acschemneuro.5b00159 Restoring Light Sensitivity in Blind Retinae Using a Photochromic AMPA Receptor Agonist L. Laprell, K. Hüll, P. Stawski, C. Schön, S. Michalakis, M. Biel, M. P. Sumser, and D. Trauner Publication Date (Web): October 23, 2015 ACS Editors’ Choice Date: November 15, 2015 Volume 7, Issue 1 DOI: 10.1021/acschemneuro.5b00234 Published: November 16, 2016 1469
DOI: 10.1021/acschemneuro.6b00368 ACS Chem. Neurosci. 2016, 7, 1469−1470
ACS Chemical Neuroscience
Editorial
Matthias Schoenberger, Arunas Damijonaitis, Zinan Zhang, Daniel Nagel, and Dirk Trauner Publication Date (Web): May 23, 2014 ACS Editors’ Choice Date: June 10, 2014 Volume 5, Issue 7 DOI: 10.1021/cn500070w Pharmacological Evidence for an Abstinence-Induced Switch in 5-HT1B Receptor Modulation of Cocaine SelfAdministration and Cocaine-Seeking Behavior Nathan S. Pentkowski, Bryan G. Harder, Samuel J. Brunwasser, Ryan M. Bastle, Natalie A. Peartree, Krishna Yanamandra, Matt D. Adams, Taleen Der-Ghazarian, and Janet L. Neisewander Publication Date (Web): December 26, 2013 ACS Editors’ Choice Date: January 15, 2014 Volume 5, Issue 3 DOI: 10.1021/cn400155t Bexarotene Blocks Calcium-Permeable Ion Channels Formed by Neurotoxic Alzheimer’s β-Amyloid Peptides Jacques Fantini, Coralie Di Scala, Nouara Yahi, JeanDenis Troadec, Kevin Sadelli, Henri Chahinian, and Nicolas Garmy Publication Date (Web): January 2, 2014 ACS Editors’ Choice Date: January 12, 2014 Volume 5, Issue 3 DOI: 10.1021/cn400183w
Turn-On Near-Infrared Fluorescent Sensor for Selectively Imaging Serotonin Kenneth S. Hettie and Timothy E. Glass Publication Date (Web): October 31, 2015 ACS Editors’ Choice Date: October 31, 2015 Volume 7, Issue 1 DOI: 10.1021/acschemneuro.5b00235 Binding of the Multimodal Antidepressant Drug Vortioxetine to the Human Serotonin Transporter Jacob Andersen, Lucy Kate Ladefoged, Danyang Wang, Trine N. Bjerre Kristensen, Benny Bang-Andersen, Anders S. Kristensen, Birgit Schiøtt, and Kristian Strømgaard Publication Date (Web): September 21, 2015 ACS Editors’ Choice Date: October 11, 2015 Volume 6, Issue 11 DOI: 10.1021/acschemneuro.5b00225 Oleocanthal Enhances Amyloid-β Clearance from the Brains of TgSwDI Mice and in Vitro across a Human Blood-Brain Barrier Model Hisham Qosa, Yazan S. Batarseh, Mohamed M. Mohyeldin, Khalid A. El Sayed, Jeffrey N. Keller, and Amal Kaddoumi Publication Date (Web): September 8, 2015 ACS Editors’ Choice Date: October 2, 2015 Volume 6, Issue 11 DOI: 10.1021/acschemneuro.5b00190 Development of a Peptidomimetic Antagonist of Neuropeptide FF Receptors for the Prevention of OpioidInduced Hyperalgesia Frédéric Bihel, Jean-Paul Humbert, Séverine Schneider, Isabelle Bertin, Patrick Wagner, Martine Schmitt, Emilie Laboureyras, Benoit̂ Petit-Demoulière, Elodie Schneider, Catherine Møllereau, Guy Simonnet, Frédéric Simonin, and Jean-Jacques Bourguignon Publication Date (Web): January 14, 2015 ACS Editors’ Choice Date: February 7, 2015 Volume 6, Issue 3 DOI: 10.1021/cn500219h Identification and Characterization of ML352: A Novel, Noncompetitive Inhibitor of the Presynaptic Choline Transporter Elizabeth A. Ennis, Jane Wright, Cassandra L. Retzlaff, Owen B. McManus, Zhinong Lin, Xiaofang Huang, Meng Wu, Min Li, J. Scott Daniels, Craig W. Lindsley, Corey R. Hopkins, and Randy D. Blakely Publication Date (Web): January 5, 2015 ACS Editors’ Choice Date: February 2, 2015 Volume 6, Issue 3 DOI: 10.1021/cn5001809 Hyperspectral Imaging Signatures Detect Amyloidopathy in Alzheimer’s Mouse Retina Well before Onset of Cognitive Decline Swati S. More and Robert Vince Publication Date (Web): October 29, 2014 ACS Editors’ Choice Date: November 26, 2014 Volume 6, Issue 2 DOI: 10.1021/cn500242z Development of a New Photochromic Ion Channel Blocker via Azologization of Fomocaine
Craig W. Lindsley, Editor-in-Chief
■
AUTHOR INFORMATION
Notes
Views expressed in this editorial are those of the author and not necessarily the views of the ACS.
■
REFERENCES
(1) http://pubs.acs.org/page/policy/editorchoice/faq.html.
1470
DOI: 10.1021/acschemneuro.6b00368 ACS Chem. Neurosci. 2016, 7, 1469−1470
